Law 360 (subscription required) has a story today about a motion filed by Hoffmann-LaRoche seeking the recusal of Judge Carol Higbee from the New Jersey Accutane Mass Tort. We can’t comment because both Reed Smith and Dechert have other matters pending in that court. However, here is a link to the motion for any of
In 2008, three Florida resident plaintiffs, in a joint trial, won jury verdicts in New Jersey state court on claims that Hoffman-La Roche had not adequately warned about the alleged link between ingesting Accutane and developing inflammatory bowel disease. Two days ago, the New Jersey Superior Court Appellate Division reversed. Sager v. Hoffmann-La Roche, Inc.
This just in. A federal MDL court in Florida has granted summary judgment in an Accutane case, holding that the drug’s warnings with respect to inflammatory bowel disease (“IBD” – the same claims that have produced significant jury awards in certain other venues that shall remain nameless) are adequate as a matter of New York
We previously wrote in less than glowing terms about the New Jersey Superior Court, Appellate Division’s decision in Kendall v. Hoffman-La Roche, Inc., slip op. (N.J. Super. A.D. August 5, 2010). We explained that “the court essentially ruled that, due to the defendant’s adequate and extensive warnings about other risks (birth defects and suicide),
We posted earlier about the Appellate Division’s 113-page whopper reversing a plaintiff’s Accutane verdict in McCarrell v. Hoffman-La Roche, Inc., 2009 WL 614484 (N.J. Super. A.D. March 12, 2009). Well, more than a year later, a second Accutane verdict meets the same fate. Here’s a copy of the opinion, Kendall v. Hoffman-La Roche,
Sometimes, we feel as though we’re writing in code.
Take the headline of this post, for example, which talks about the Accutane MDL IBD cases.
So be it, we suppose: There’s not a very good alternative.
Two years ago, Judge Moody, who’s overseeing the Accutane MDL, granted Hoffman-La Roche Inc’s motion to exclude plaintiffs’ general
This just in:
Adam W. Mason had won a $7 million jury verdict in Florida state court on a claim that Hoffman-La Roche had not adequately warned about the alleged link between ingesting Accutane and developing inflammatory bowel disease.
This morning, in a per curiam decision, the Florida First District Court of Appeal reversed. Hoffman-La
A couple of brief notes on new decisions:
(1) In Accutane litigation, plaintiff’s expert Ronald Fogel is now 0-2 under Daubert. The latest opinion excluding his testimony does so because his opinions overreached the medical literature on which they were based. The holding:
Both [the articles], in their review of the existing literature, case
This just in:
Yesterday afternoon, the Eleventh Circuit affirmed, in an unpublished opinion, the trial court’s grant of summary judgment in an Accutane-suicide case. Stupak v. Hoffman-La Roche, Inc., No. 07-15980, slip op. (11th Cir. June 10, 2009) (link here).
In a nutshell, Stupak, age 17, was prescribed Accutane in December 1999 to
We know that headline is boring: “Accutane: McCarrell Remanded For New Trial.”
But give us a break.
Levine comes down. We’re duty-bound to blog about it. The press calls for reactions to it. We’re writing about the case in print media. We’re being asked to speak about the case.
And then there’s our real jobs: